These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 19110088

  • 1. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
    Davidson MH, Gandhi SK, Ohsfeldt RL, Fox KM.
    Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
    [Abstract] [Full Text] [Related]

  • 2. Medicare-eligible patients diagnosed with atherosclerosis: patterns in statin therapy and lipid monitoring.
    Ohsfeldt RL, Gandhi SK, Fox KM.
    Curr Med Res Opin; 2009 Jun; 25(6):1403-11. PubMed ID: 19422282
    [Abstract] [Full Text] [Related]

  • 3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 4. Treatment of hypercholesterolemia in patients with diabetes at a family practice office.
    Camenga D, Gill JM.
    Del Med J; 2003 Nov; 75(11):415-20. PubMed ID: 14870630
    [Abstract] [Full Text] [Related]

  • 5. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
    Fox KM, Gandhi SK, Ohsfeldt RL, Davidson MH.
    Am J Manag Care; 2007 Dec; 13 Suppl 10():S270-5. PubMed ID: 18095777
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Bays HE.
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP.
    Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA, Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators.
    Am J Cardiol; 2009 Sep 15; 104(6):798-804. PubMed ID: 19733714
    [Abstract] [Full Text] [Related]

  • 11. Achieving target cholesterol levels in diabetic patients: potency of the statin or potency of the physician?
    Shani M, Dresner J, Vinker S.
    Isr Med Assoc J; 2008 May 15; 10(5):354-7. PubMed ID: 18605358
    [Abstract] [Full Text] [Related]

  • 12. Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation).
    Assmann G, Benecke H, Neiss A, Cullen P, Schulte H, Bestehorn K.
    Eur J Cardiovasc Prev Rehabil; 2006 Oct 15; 13(5):776-83. PubMed ID: 17001218
    [Abstract] [Full Text] [Related]

  • 13. Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study.
    Van Ganse E, Laforest L, Alemao E, Davies G, Gutkin S, Yin D.
    Curr Med Res Opin; 2005 Sep 15; 21(9):1389-99. PubMed ID: 16197657
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH.
    Am J Cardiol; 2007 Nov 15; 100(10):1499-501. PubMed ID: 17996508
    [Abstract] [Full Text] [Related]

  • 16. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.
    Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM.
    Liver Transpl; 2009 May 15; 15(5):504-8. PubMed ID: 19399742
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
    Tachibana E, Watanabe I, Nagao K, Kanmatsuse K.
    J Cardiol; 2000 Apr 15; 35(4):277-85. PubMed ID: 10791271
    [Abstract] [Full Text] [Related]

  • 19. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival.
    Leeper NJ, Ardehali R, deGoma EM, Heidenreich PA.
    Circulation; 2007 Aug 07; 116(6):613-8. PubMed ID: 17664373
    [Abstract] [Full Text] [Related]

  • 20. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
    Stacy TA, Egger A.
    J Manag Care Pharm; 2006 Aug 07; 12(9):745-51. PubMed ID: 17249907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.